Urgent.News

One page, thousands of outlets. See who else covered it.

Editions

Health & Medicine

New mRNA vaccine could reduce the recurrence and spread of skin cancer

Merck and Moderna announced a successful late-stage trial for a melanoma vaccine. NPR's Leila Fadel talks to Dr. Robert Vonderheide of Penn Medicine and the American Association for Cancer Research.

New mRNA vaccine could reduce the recurrence and spread of skin cancer

We haven't written up this one. NPR Health has the full story — the link below goes straight to it.

Read the original at npr.org →

More in Health & Medicine

More from Thursday 20 August →